Literature DB >> 12534352

Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.

Tomasz Bednarczuk1, Yuji Hiromatsu, Tomoka Fukutani, Krystian Jazdzewski, Piotr Miskiewicz, Maria Osikowska, Janusz Nauman.   

Abstract

OBJECTIVE: The development and severity of Graves' ophthalmopathy (GO) may result from a complex interplay of genetic and environmental factors. The aim of this study was to investigate the association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors (age, sex, cigarette smoking) with GO in two different populations, Polish-Caucasians and Japanese.
DESIGN: We investigated the distribution of CTLA-4 A49G polymorphism in 264 Caucasian patients with Graves' disease (GD), of which 95 had clinically evident GO (NOSPECS class >or=3) and 319 Japanese patients with GD, of which 99 had ophthalmopathy. The control groups consisted of healthy Polish adults (n=194), Polish centenarians (n=51) and Japanese adults (n=112).
RESULTS: Allele G and G/G genotype were significantly increased in Caucasian patients with GD (48% and 25% respectively) and in Japanese patients with GD (69% and 47% respectively) compared with control groups. There were no significant differences in the G allele and G/G genotype frequencies in GO patients compared with GD patients without ophthalmopathy. Multiple logistic regression analysis demonstrated that cigarette smoking (P=0.03, odds ratio (OR)=1.7) and age of onset of GD over 42 Years (P=0.08; OR=1.6) were contributing factors associated with susceptibility to GO in Polish patients. In Japanese patients, a younger age of onset of GD had an effect on the development of GO (P=0.02, OR=1.8).
CONCLUSIONS: (i) Allele G and G/G genotype confer genetic susceptibility to GD; (ii) CTLA-4 A49G polymorphism is not associated with the development of GO; (iii) different non-genetic factors may contribute to GO in different populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534352     DOI: 10.1530/eje.0.1480013

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  22 in total

1.  The A946T polymorphism in the interferon induced helicase gene does not confer susceptibility to Graves' disease in Chinese population.

Authors:  Ze-Fei Zhao; Bin Cui; Hao-Yan Chen; Shu Wang; Imelda Li; Xue-Jiang Gu; Li Qi; Xiao-Ying Li; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2007-11-17       Impact factor: 3.633

2.  A Study on the Level of T(3), T(4), TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves' Hyperthyroidism among South Indian Population.

Authors:  P Veeramuthumari; W Isabel; K Kannan
Journal:  Indian J Clin Biochem       Date:  2010-12-29

3.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Authors:  Krystian Jazdzewski; Tomasz Bednarczuk; Magdalena Stepnowska; Sandya Liyanarachchi; Krystyna Suchecka-Rachon; Janusz Limon; Krzysztof Narkiewicz
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

4.  Intercellular adhesion molecule 1 gene polymorphisms do not contribute to Graves' disease in Chinese patients.

Authors:  Shu Wang; Hua Sun; Hao-Yan Chen; Ze-Fei Zhao; Yang Yang; Yong-Ju Zhao; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

5.  Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study.

Authors:  Alina Kurylowicz; Piotr Miśkiewicz; Ewa Bar-Andziak; Janusz Nauman; Tomasz Bednarczuk
Journal:  Thyroid Res       Date:  2009-11-03

Review 6.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

7.  Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.

Authors:  Beata Jurecka-Lubieniecka; Rafal Ploski; Dorota Kula; Aleksandra Krol; Tomasz Bednarczuk; Zofia Kolosza; Andrzej Tukiendorf; Sylwia Szpak-Ulczok; Anita Stanjek-Cichoracka; Joanna Polanska; Barbara Jarzab
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

9.  CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis).

Authors:  Dorota Pastuszak-Lewandoska; Ewa Sewerynek; Daria Domańska; Aleksandra Gładyś; Renata Skrzypczak; Ewa Brzeziańska
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

10.  Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.

Authors:  Xiaoyu Si; Xiufeng Zhang; Wenru Tang; Ying Luo
Journal:  Exp Ther Med       Date:  2012-06-20       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.